Publications

Developing a compendium of policy levers and opportunities to reduce exposure to antineoplastic (cytotoxic) drugs in pharmacies

Description

Presents results of a study aiming to inform policymakers about policy levers and opportunities to reduce occupational exposure to antineoplastic (chemotherapy drugs or cytotoxic drugs) drugs.

Updated

June 1, 2020

Tags
ADs OHS Futures OHS Futures Research Funding Program Occupational Health and Safety Futures Research Funding Program antineoplastic drugs carcinogens cytotoxic drugs pharmacies workplace conditions

Title and publication information

Type
Report
Extent

77 pages

Frequency

Once

Publisher / Creator Information

Publisher

Jobs, Economy and Northern Development

Contributor

Peters, Cheryl

Contributor

Brenner, Darren

Contributor

Koehoorn, Mieke

Contributor

McLeod, Chris

Contributor

Palmer, Alison

Subject Information

Resource Dates

Date Created

2020-06-01

Date Added

2023-06-01T19:41:45.455624

Date Modified

2020-06-01

Date Issued

2023-06-07

Identifiers

Usage / Licence

Usage Considerations

Funding for this research was provided by the OHS Futures Research Funding Program. The research was not conducted by the Government of Alberta and any statements, findings or conclusions presented are not endorsed by the GoA. Requests for further information or questions about the research should be addressed to the authors of the report directly.

Licence

No licence

Contact

Contact Name

OHS Futures Research Grant Program

Contact Email

OHSFutures@gov.ab.ca